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Abstract—Mechanical alternans (MA) is a powerful predic-
tor of adverse prognosis in patients with heart failure and
cardiomyopathy, but its use remains limited due to the need
of invasive continuous arterial pressure recordings. This
study aims to assess novel cardiovascular correlates of MA in
the intact human heart to facilitate affordable and non-
invasive detection of MA and advance our understanding of
the underlying pathophysiology. Arterial pressure, respira-
tion, and ECG were recorded in 12 subjects with healthy
ventricles during voluntarily controlled breathing at different
respiratory rate, before and after administration of beta-
blockers. MA was induced by ventricular pacing. A total of
67 recordings lasting approximately 90 s each were analyzed.
Mechanical alternans (MA) was measured in the systolic
blood pressure. We studied cardiovascular correlates of MA,
including maximum pressure rise during systole (dPdtmax),
pulse arrival time (PAT), pulse wave interval (PI), RR
interval (RRI), ECG QRS complexes and T-waves. MA was
detected in 30% of the analyzed recordings. Beta-blockade
signiﬁcantly reduced MA prevalence (from 50 to 11%,
p < 0.05). Binary classiﬁcation showed that MA was
detected by alternans in dPdtmax (100% sens, 96% spec),
PAT (100% sens, 81% spec) and PI (80% sens, 81% spec).
Alternans in PAT and in PI also showed high degree of
temporal synchronization with MA (80 ± 33 and 73 ± 40%,
respectively). These data suggest that cardiac contractility is
a primary factor in the establishment of MA. Our ﬁndings
show that MA was highly correlated with invasive measure-
ments of PAT and PI. Since PAT and PI can be estimated
using non-invasive technologies, these markers could poten-
tially enable affordable MA detection for risk-prediction.
Keywords—Mechancial alternans, Pulse arrival time, Pulse
transit time, Electrical alternans.
INTRODUCTION
Mechanical alternans (MA), also known as pulsus
alternans, is deﬁned as a blood pressure change
occurring on an every other beat basis, which can
manifest in a succession of strong and weak pulses.
Since its discovery in the late nineteenth century,17 it
has been recognized as a marker of cardiovascular
impairment given the association with increased mor-
tality in heart failure11 and idiopathic dilated car-
diomyopathy.9,14
Mechanical alternans is a manifestation of broader
phenomenon known as cardiac alternans, which
involves the excitation–contraction coupling and in-
cludes electrical alternans, a phenomenon describing
electrical conduction and/or repolarization changes on
an every other beat basis. Electrical alternans manifests
as a beat to beat change in the T-wave and/or QRS
complex morphology, known as T-wave alternans
(TWA) and/or QRS alternans (QRSA), respectively,
which are established predictors of sudden cardiac
death.4,17,26,31,33
The interaction between mechanical and electrical
alternans is still unclear, mainly due to the limited
number of studies that have included simultaneous
recordings of both types of alternans. Previous work
has reported both strong27 and moderate10,11,13 corre-
lations between mechanical and electrical alternans.
Mechanical and electrical alternans may be driven by
different mechanisms, with the former due to hemo-
dynamic and/or inotropic alterations29 and the latter
due to discrete local disturbances within the conduc-
tion system or myocardium17,33 providing comple-
mentary information about cardiac vulnerability.
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The use of MA as a risk stratiﬁcation marker is
appealing but limited by the invasiveness of arterial
pressure recordings and the cost of non-invasive con-
tinuous bloodpressuremonitors. The aimof this study is
to assess novel cardiovascular correlates of MA in the
intact human heart using invasive derived measure-
ments to advance our understanding of its pathophysi-
ology to facilitate aﬀordable non-invasive detection.
METHODS
Continuous and synchronous recordings of invasive
arterial blood pressure, respiration (chest movement)
and the limb-lead electrograms (ECGs) were obtained
from 12 subjects before routine clinical radiofrequency
ablation procedures for atrial ﬁbrillation in the cardiac
catheterization lab at the St Thomas’ Hospital in
London, as described previously.8,30
All subjects had normal ventricular function and
none of them were known to have ventricular scar or
disordered conduction due to bundle branch abnor-
malities. Studies were performed in the unsedated state
and cardio-active medications were discontinued for
5 days before the study.
Arterial blood pressure wasmeasured from a femoral
artery with a continuous-ﬂush pressure transducer sys-
tem (Tru-Wave PX600F; Ed-wards Lifesciences, Irvine,
CA). The subject’s breathing cycle was monitored using
a custom-constructed tension sensor ﬁxed to a freely
expandable band placed around the chest/abdomen
(adapted from a RESPeRATE device; InterCure, New
York, NY). ECG, blood pressure and respiration were
synchronously recorded and digitized at 1200 Hz (En-
site 3000; Endocardial Solutions).
Experimental Protocol
During the study, heart rate was clamped by right
ventricular pacing using a Biotronik (Berlin, Germany)
stimulator (model UHS 3000) throughout the experi-
ment. Mechanical alternans was induced by ventricular
pacing, which was applied at twice the diastolic
threshold and 2 ms pulse width, at a cycle length > 20
beats/min faster than the intrinsic AF rate (median of
pacing interval equal to 500 ms). Breathing was regu-
lated voluntary at four ﬁxed rates (6, 9, 15, and 30
breaths/min) for 90 s each, in random order. The
subjects were instructed by a video monitor that dis-
played a computer-generated animation of lung vol-
ume (implemented in LabVIEW software; National
Instruments, Austin, TX). Paced breathing was prac-
ticed before study commencement. The breathing
protocol was ﬁrst performed under control conditions.
All patients then received beta-blocker (metoprolol)
intravenously and the breathing protocol was repeated.
This resulted in a total of 12 9 4 9 2 = 96 recording
of 90 s duration with controlled breathing and heart
rate.
Analysis of Recordings
Measurements were analyzed oﬄine. ECG and
arterial pressure signals were band-pass ﬁltered
between 0.5 and 35 Hz to attenuate noise. The signals
were then used to determine the following indices
(Fig. 1):
(1) Systolic blood pressure (SBP) as well as blood
pressure measured 8 and 16 ms before and after
the systolic peak (total of 5 blood pressure
measures per pulse).
(2) The maximum upstroke of the pulse (dPdtmax),
computed as the maximum derivative of the
blood pressure series during systole.
(3) T-wave amplitude at the peak of the T-wave as
well as T-wave amplitude measured 8 and 16 ms
before and after the T-wave peak (total of 5
measures per T-wave).
(4) QRS-wave amplitude as well as QRS-wave
amplitude measured 8 and 16 ms before and
after the QRS peak (total of 5 measures per QRS
complex). The QRS wave amplitude was mea-
sured as the R-wave amplitude for positive QRS
complexes, or S wave amplitude for negative
QRS complexes.
(5) RR interval, as the interval between two con-
secutive R-waves in the ECG lead measured
from the best signal quality among leads I, II
and III.
(6) Pulse wave interval (PI), as the interval between
systolic peaks of consecutive beats.
(7) Pulse arrival time (PAT), measured as the
interval between the occurrence of the R-wave
peak and the dPdtmax within the same heartbeat.
Beats for which any of these measurements could
not be determined (e.g. ectopic beats) were replaced by
the mean value of the series. Series were rejected if the
interpolated values constituted more than 10% of the
total number of measurements.
ALTERNANS DETECTION
Alternans was detected using a standard spectral
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YD n; b½  ¼ Y n; b½   Y½n; b 1
where Y represents the time series of one of the
investigated markers (SBP, dPdtmax, QRS, T-wave
amplitude, RRI, PI or PAT), with n = 1:N being the
number of samples taken from each marker within
each beat, and b = 1:B the number of beats. As shown
in Fig. 1, N = 5 for SBP, QRS-wave and T-wave
amplitudes, while N = 1 for RRI, dPdtmax, PI and
PAT. The Fourier transform was used to estimate the
power-spectrum of YD n; b½ (along b) using a moving
window L beats wide and centered at heartbeat b:
















The alternans magnitude MYaltðbÞ at beat b was then
computed by taking the square root of the sum of
PYalt b; fð Þ between 0.46 and 0.5 cycles/beat1,28:
MYalt bð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
0:46<f  0:5






Results will be given for L = 16, 32 and 64 beats.
Statistical Analysis
The interaction between MA and other markers was
assessed both in terms of inter-recordings binary clas-
siﬁcation (whether a recording can be correctly classi-
ﬁed as showing or not-showing mechanical alternans)
and intra-recording temporal correlation (the degree of
synchronization between mechanical alternans and
alternans in the investigated markers).
The inter-recordings binary classiﬁcation was used
to investigate the accuracy of each of the investigated
markers to detect recordings with and without MA.
The sensitivity of each marker to predict MA was de-
ﬁned as the fraction of the recordings with MA that
were correctly identiﬁed, whereas the speciﬁcity was
deﬁned as the fraction of recordings without MA that
were correctly identiﬁed. A recording was classiﬁed as
MA positive if the beat-to-beat SBP magnitude,
MSBPalt ðbÞ, exceeded the alternans threshold of 4 mmHg,
i.e. MSBPalt bð Þ>4mmHg, for at least 5% of the total
number of beats within the whole recording. Alternans
in the investigated markers, YD, was detected when
MYaltðbÞ exceeded a threshold for at least 5% of the
total number of beats within the whole recording. The
optimal threshold was determined using ROC analysis.
Recordings were divided into a training and a testing
data set, each one containing the same number of
recordings from different patients to ensure indepen-
dence.
For each cardiovascular correlate, the optimal
threshold to detect MA was estimated in the training
set as the threshold that corresponded to the point of
the ROC curve that maximised the product sensitiv-
ity 9 speciﬁcity.
The intra-recording temporal correlation between
the investigated markers and MA was quantiﬁed by
computing temporal sensitivity (tSens) and speciﬁcity
(tSpec). Temporal sensitivity, tSensXY, was deﬁned as
the duration of the interval during which alternans was
simultaneously present in XðbÞ and YðbÞ divided by the
duration of the interval during which alternans was
present in YðbÞ. Temporal speciﬁcity, tSpecXY, was
deﬁned as the duration of the interval during which
alternans was simultaneously absent in XðbÞ and YðbÞ
divided by the duration of the interval during which
alternans was absent in YðbÞ.
Figure 2 shows an example of the temporal agree-
ment between MA and PAT alternans (PATA) with
tSensPATA;MA ¼ 0:95 (95% temporal overlap between
PATA and MA) and tSpecPATA;MA ¼ 0:74 (74% of
temporal overlap between absence of PATA and ab-
sence of MA, indicating the presence of PATA at times
when MA was absent).
FIGURE 1. Overview of the obtained measurements from the
blood pressure and ECG waveforms. SBP systolic blood
pressure, dPdtm (dP/dt)max, Rw peak of the R-wave, Tp peak
of the T-wave, PI pulse interval, PAT pulse arrival time, RRI RR
interval. Note the broad QRS complexes as a result of
ventricular pacing (corresponding pacing artefacts are
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The Fisher exact probability test was used to test
whether the proportion of recordings with MA was
statistically diﬀerent across diﬀerent respiratory rates.
We applied McNemar v2 test for paired nominal data
to compare the proportion of recordings with MA
during control and following administration of beta-
blocker.
RESULTS
From the 96 breathing episodes, pressure recordings
were available in 84, from which 67 recordings (80%)
were eligible for analysis while 17 recordings were
discarded due to high number of ectopic beats (number
of ectopics exceeding 10% of total number of beats).
Administration of beta-blocker was associated with a
signiﬁcant reduction of the mean dPdtmax:
998 ± 383 vs. 797 ± 331 mmHg/s, p = 0.004,
whereas SBP showed a tendency to decrease: 138 ± 19
vs. 130 ± 25 mmHg, p = 0.7.
Examples of recordings with and without MA are
shown in Fig. 3. Episodes of MA were observed in 7
out of 12 subjects and detected in 30% of the available
recordings. No signiﬁcant differences were found in the
proportions of recordings with MA across different
respiratory rates (p = 0.8, Fig. 4a). However, admin-
istration of beta-blocker was associated with a signiﬁ-
cantly reduced the proportion of recordings with MA
from 50 to 11% (p < 0.05) (Fig. 4b).
The results of alternans inter-recordings binary
classiﬁcation analysis are shown in Fig. 5 and Table 1.
Alternans was present in all markers with similar
prevalence (Table 1), which was however highest for
PATA and PIA: 43 and 37%, respectively. Alternans
in dPdtmax showed the strongest correlation with MA
with an accuracy of 97% (100% sensitivity, 96%
speciﬁcity). The corresponding optimal alternans
threshold to predict MA was 72 mmHg/s. PAT alter-
nans (PATA) and PI alternans (PIA) detected MA
with accuracies equal to 87% (100% sensitivity, 81%
speciﬁcity) and 81% (80% sensitivity, 81% speciﬁcity),
respectively, and optimal thresholds equal to 4.5 and
3.7 ms, respectively. The linear correlation between
PATA and MA magnitudes was modest but signiﬁcant
(q = 0.63, p < 0.001). No signiﬁcant correlation was
found between MA and PIA magnitudes (q = 0.29,
p = 0.13). Moderate to high inter-recordings classiﬁ-
cation accuracy were observed for RRI alternans
(RRIA, acc = 78%), TWA (acc = 79%) and QRSA
(acc = 70%), see Table 1. The corresponding alter-
nans thresholds for optimal accuracy to detect MA
were 2.8 ms, 37, and 14 lV, respectively. It is worth
noting that very similar results were obtained when
using the full data-set for both training and testing
(Supplementary Fig. 1 and Supplementary Table 1).
The eﬀect of diﬀerent window lengths of the sliding
window for alternans detection on the accuracy of
PATA and PIA is shown in Fig. 6. No major differ-
ences were found. However, the sensitivity of PATA to
detect MA decreased from 92% for L = 32 beats to
88% for L = 16 beats.
The temporal intra-recording correlation between
markers of alternans is presented in Table 2. There was
a moderate to high temporal synchronization with MA
for PATA tSensPATA;MA ¼ 80  33%  and PIA
tSensPIA;MA ¼ 73  40% , whereas mean
tSensTWA;MA, tSensQRSA;MA, and tSensRRIA;MA were
within the range 48–64%.
DISCUSSION
The aim of this study was to advance our under-
standing of the pathophysiology of MA and facilitate
aﬀordable non-invasive detection by studying its cor-
relation with other cardiovascular markers in the intact
FIGURE 2. Temporal agreement between mechanical
alternans (MA) and alternans in the pulse arrival time
(PATA). Upper panel shows the raw BP trace with temporal
episodes of MA around 10 and 20 s. The lower panel show the
temporal agreement between MA (indicated by grey shading)
and PATA: TP true positive: alternans in both systolic blood
pressure (SBP) and PAT, TN true negative: absence of
alternans in both markers, FP false positive: PATA during
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human heart. The main ﬁndings are: (1) Pacing-in-
duced MA is almost always accompanied by alternans
in dPdtmax and the prevalence decreased following
beta-blocker administration; (2) Alternans in PAT and
PI were highly correlated with MA (accuracy > 0.84);
(3) Moderate correlation was found between MA and
RRIA, TWA and QRSA.
The ﬁrst main ﬁnding indicates that cardiac con-
tractility is a primary factor in the establishment of
MA. It was observed that the cardiovascular markers
with better correlation with MA are all associated with
contractility: dPdtmax is considered a marker of cardiac
contractility in itself, while PAT and PI strongly de-
pend on the pre-ejection period and pulse wave
FIGURE 3. Examples of blood pressure and ECG traces during presence of MA (a) and absence (b). SBP systolic blood pressure,
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velocity, which in turn depend on contractility. Fur-
thermore, we observed a signiﬁcant decrease in MA
prevalence after beta-adrenergic blockade. Since beta-
blockers reduce cardiac inotropy, this further supports
a direct link between MA and cardiac contractility and
is in line with previous work showing a reduction in
MA occurrence in patients with chronic heart failure
following long-term beta-blocker therapy.12
Regarding the second main ﬁnding, the similar
accuracy with which PAT and PI detected MA is most
probably due to the fact that PAT is an important
component of PI.32 The analysis of intra-recording
temporal correlation showed that PAT and PI were
not only able to correctly classify recordings as MA
positive or negative but they also offer the possibility
of tracking MA intermittent behavior with good
accuracy. The PAT is equal to the sum of PTT, the
time interval required for a pressure wave to travel
between two sites (typically between a proximal site
and a distal site) in the arterial tree, and the pre-ejec-
tion period. The pre-ejection period is determined by
the ventricular electro-mechanical delay and isovolu-
mic contraction period.6 Therefore, the close associa-
tion between MA and PAT alternans is likely to be
mediated by beat-to-beat ﬂuctuations in the pre-ejec-
tion period induced by changes in contractility. The
possibility of measuring blood pressure non-invasively
through either the PTT or the PAT has been exten-
sively investigated, but it remains controversial.32 The
results of this study indicate that although PAT may
not provide accurate estimates of SBP (at least without
calibration), it can accurately track rapid oscillations
in SBP. An important implication is that MA can be
detected by analyzing beat to beat variations in the
pulse interval, which can be measured non-invasively
with affordable technology such as for example pho-
toplethysmography, providing a potential surrogate
for MA as an independent predictor of cardiovascular
mortality without the need of invasive recordings and
expensive technology.3
The moderate correlation (75%) between MA and
RRIA was unexpected since the studies were con-
ducted during ventricular pacing at a ﬁxed heart rate.
This may be due to an interaction between the pre-
ejection period and RRI, mediated by conduction
velocity changes which reﬂect in changes in the QRS
morphology. Another possible link between MA and
alternans in the RRI may be mediated by the barore-
ﬂex.15,22 The weakest correlation with MA was found
for QRS and T-wave alternans, which is in line with
previous observations that T-wave alternans can occur
in the absence of MA and vice versa.10,13
This study has a balanced number of recordings
with and without MA, which is important for accurate
sensitivity and speciﬁcity estimation. Accuracy was
measured in a testing data-set independent of the
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training data-set. Similar results were obtained when
using the full data-set for both training and testing. A
likely explanation for the relatively high prevalence of
MA may be the relatively high pacing rate (median
cycle length was equal to 500 ms). One of the proposed
mechanisms underlying the establishment of MA is
based on the hypothesis that a sequence of weak and
strong beats is maintained by the succession of these
events: a beat associated with low end-diastolic volume
contracts with low force due to Frank-Starling mech-
anism and has high end-systolic volume (weak beat).
The following beat has high end-diastolic volume and
contracts with high force (strong beat) and therefore
has low end-systolic volume. The next beat will have
low-end diastolic volume and low force and so on. The
short cycle length as a result of the high pacing rate
would accentuate this process because it reduces the
time available for diastolic ﬁlling.5 Previous studies
have indeed shown that MA is more prevalent and
likely to be sustained at higher heart rates.5,9 Fur-
thermore, ventricular pacing alters contractility which
may also facilitate MA induction. The prevalence of
RRIA and QRSA was lower in the training than in the
full data-set. This is probably due to the weak associ-
ation between these markers and MA, which makes the
estimation of the best threshold for MA detection
through ROC analysis unreliable.
The main focus of this work was to explore the
possibility of indirectly detect MA using pulse arrival
time and pulse interval. Further studies are needed to
determine the best estimator for mechanical alternans.
In this study, we have implemented a modiﬁed spectral
method in which MA is detected by comparing the
spectral power in an ad-hoc alternans spectral band
with the absolute threshold (4 mmHg) consistently
used in previous clinical work.9,11–13 The alternans’
spectral band was extended to include frequencies
within 0.46–0.5 Hz to reduce the effect of phase
resetting, where a change in the alternans phase results
in a shift of the alternans spectral peak toward slightly
lower frequencies.1 Future research should focus on
the optimization of mechanical alternans detection by
testing different advanced methodologies proposed for
T-wave alternans detection16,19–21 including how to
compensate for phase resetting in the alternans se-
quence due to ventricular premature contractions.20
Previous studies have demonstrated that the pho-
toplethysmographic signal can be used to measure
other important markers of cardiovascular risk such as
heart rate variability7 respiratory rate,23 heart rate
FIGURE 5. ROC curves for tested markers to predict
recordings with mechanical alternans. RRI RR interval, PAT
pulse arrival time, PI pulse wave interval, QRSA QRS-complex
alternans, TWA T-wave alternans.
TABLE 1. Accuracy, sensitivity, and specificity of investigated cardiovascular markers to detect mechanical alternans evaluated
in the testing data-set.
Prev. (%) MA DPDTA PATA PIA RRIA TWA QRSA
MA 30 1 (1/1) 0.97 (1/0.96) 0.87 (1/0.81) 0.81 (0.8/0.81) 0.78 (0.5/0.89) 0.79 (0.85/0.77) 0.7 (0.3/0.87)
DPDTA 33 1 (1/1) 0.87 (0.95/0.82) 0.84 (0.82/0.84) 0.75 (0.45/0.89) 0.79 (0.82/0.78) 0.67 (0.27/0.87)
PATA 43 1 (1/1) 0.76 (0.66/0.84) 0.64 (0.34/0.87) 0.81 (0.76/0.84) 0.63 (0.28/0.89)
PIA 37 1 (1/1) 0.73 (0.44/0.9) 0.72 (0.68/0.74) 0.66 (0.28/0.88)
RRIA 22 1 (1/1) 0.69 (0.73/0.67) 0.78 (0.4/0.88)
TWA 42 1 (1/1) 0.73 (0.39/0.97)
QRSA 18 1 (1/1)
MA mechanical alternans, DPDTA dPdtmax alternans, PATA pulse arrival time alternans, PIA pulse wave interval alternans, TWA T-wave
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turbulence,2 atrial ﬁbrillation18 etc. The integration of
markers related to different mechanisms of cardiac
instability has been shown to improve cardiac risk
prediction,25 and the combination of MA with other
markers of risk derived from PI analysis should be
investigated in future studies.
CONCLUSION
The results from this study indicate cardiac con-
tractility as a primary factor in the establishment of
MA. We demonstrated that invasive derived mea-
surements of PATA and PIA are able to detect MA
with high accuracy. Future studies should investigate
whether PAT and PI measured by non-invasive and
aﬀordable technology such as photoplethysmography,
currently widely incorporated in wearable devices, can
also provide accurate estimation of MA.
ELECTRONIC SUPPLEMENTARY MATERIAL
The online version of this article (https://doi.org/10.
1007/s10439-019-02221-4) contains supplementary
material, which is available to authorized users.
OPEN ACCESS
This article is distributed under the terms of the
Creative Commons Attribution 4.0 International Li-
cense (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and
reproduction in any medium, provided you give
appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons li-
cense, and indicate if changes were made.
REFERENCES
1Armoundas, A. A., T. Mela, and F. M. Merchant. On the
estimation of T-wave alternans using the spectral fast
fourier transform method. Heart Rhythm 9:449–456, 2012.
2Bauer, A., et al. Standards of measurement, physiological
interpretation, and clinical use. International Society for
Holter and Noninvasive Electrophysiology Consensus. J.
Am. Coll. Cardiol. 52:1353–1365, 2008.
3Besleaga, T., et al. Non-invasive detection of mechanical
alternans utilizing photoplethysmography. IEEE J. Biomed
Health Inform 2018. https://doi.org/10.1109/JBHI.2018.28
82550.
4Bloomﬁeld, D. M., et al. Microvolt T-wave alternans dis-
tinguishes between patients likely and patients not likely to
FIGURE 6. Accuracy (Acc), sensitivity (Sens), and specificity (Spec) to predict mechanical alternans using alternans in pulse
arrival time (PAT) and pulse width interval (PIA) for different analysis window lengths (L). The percentage of recordings with
alternans is shown between brackets on top of the bars.
TABLE 2. Temporal agreement between mechanical
alternans and alternans of the investigated cardiovascular
markers: mean tSens 6 standard deviation and mean
tSpec 6 standard deviation.
tSens tSpec
DPDTA 0.93(± 0.15) 0.7(± 0.38)
PATA 0.8(± 0.3) 0.74(± 0.38)
PIA 0.73(± 0.4) 0.54(± 0.43)
RRIA 0.48(± 0.46) 0.68(± 0.46)
QRSA 0.51(± 0.43) 0.62(± 0.43)
TWA 0.64(± 0.42) 0.55(± 0.43)




VAN DUIJVENBODEN et al.
beneﬁt from implanted cardiac deﬁbrillator therapy: A
solution to the Multicenter Automatic Deﬁbrillator
Implantation Trial (MADIT) II conundrum. Circulation
110:1885–1889, 2004.
5Euler, D. E. Cardiac alternans: mechanisms and patho-
physiological signiﬁcance. Cardiovasc. Res. 42:583–590,
1999.
6Geddes, L., M. Voelz, C. Babbs, J. Bourland, and W.
Tacker. Pulse transit time as an indicator of arterial blood
pressure. Psychophysiology 18:71–74, 1981.
7Gil, E., et al. Photoplethysmography pulse rate variability
as a surrogate measurement of heart rate variability during
non-stationary conditions. Physiol. Meas. 31:1271, 2010.
8Hanson, B., et al. Oscillatory behavior of ventricular action
potential duration in heart failure patients at respiratory
rate and low frequency. Front. Physiol. 5:414, 2014.
9Hirashiki, A., et al. Prognostic value of pacing-induced
mechanical alternans in patients with mild-to-moderate
idiopathic dilated cardiomyopathy in sinus rhythm. J. Am.
Coll. Cardiol. 47:1382–1389, 2006.
10Kashimura, T., et al. Relative refractoriness of left ven-
tricular contraction underlies human tachycardia-induced
mechanical and electrical alternans. PACE 37:197–206,
2014.
11Kim, R., et al. Mechanical alternans is associated with
mortality in acute hospitalized heart failure prospective
mechanical alternans study (mas). Circulation 7:259–266,
2014.
12Kodama, M., et al. Changes in the occurrence of
mechanical alternans after long-term b-blocker therapy in
patients with chronic heart failure. Jpn. Circ. J. 65:711–716,
2001.
13Kodama, M., et al. Linkage between mechanical and
electrical alternans in patients with chronic heart failure. J.
Cardiovasc. Electrophysiol. 15:295–299, 2004.
14Kodama, M., et al. Ventricular ﬁbrillation in two cases
with dilated cardiomyopathy and mechanical alternans.
PACE 28:1347–1349, 2005.
15La Rovere, M. T., G. D. Pinna, and G. Raczak. Baroreﬂex
sensitivity: measurement and clinical implications. Ann.
Noninvasive Electrocardiol. 13:191–207, 2008.
16Laguna, P., M. Ruiz, G. Moody, and R. Mark. Repolar-
ization alternans detection using the KL transform and the
beatquency spectrum. Comput. Cardiol. 1996:673–676,
1996.
17Laurita, K. R., and D. S. Rosenbaum. Cellular mechanisms
of arrhythmogenic cardiac alternans. Prog. Biophys. Mol.
Biol. 97:332–347, 2008.
18Lee, J., B. A. Reyes, D. D. McManus, O. Maitas, and K.
H. Chon. Atrial ﬁbrillation detection using an iPhone 4S.
IEEE Trans. Biomed. Eng. 60:203–206, 2013.
19Martı´nez, J. P., and S. Olmos. Methodological principles of
T wave alternans analysis: a uniﬁed framework. IEEE
Trans. Biomed. Eng. 52:599–613, 2005.
20Martı´n-Yebra, A., et al. Post-ventricular premature con-
traction phase correction improves the predictive value of
average T-wave alternans in ambulatory ECG recordings.
IEEE Trans. Biomed. Eng. 65:635–644, 2018.
21Monasterio, V., et al. Average T-wave alternans activity in
ambulatory ECG records predicts sudden cardiac death in
patients with chronic heart failure. Heart Rhythm 9:383–
389, 2012.
22Orini, M., P. Laguna, L. T. Mainardi, and R. Bailo´n.
Assessment of the dynamic interactions between heart rate
and arterial pressure by the cross time-frequency analysis.
Physiol. Meas. 33:315–331, 2012.
23Orini, M., M. D. Pelaez-Coca, R. Bailon, and E. Gil.
Estimation of spontaneous respiratory rate from photo-
plethysmography by cross time-frequency analysis. Com-
put. Cardiol. 2011:661–664, 2011.
24Orini, M., et al. Comparative evaluation of methodologies
for T-wave alternans mapping in electrograms. IEEE
Trans. Biomed. Eng. 61:308–316, 2014.
25Ramı´rez, J., et al. Sudden cardiac death and pump failure
death prediction in chronic heart failure by combining
ECG and clinical markers in an integrated risk model.
PLoS ONE 12:e0186152, 2017.
26Rosenbaum, D. S., et al. Electrical alternans and vulnera-
bility to ventricular arrhythmias. N. Engl. J. Med. 330:235–
241, 1994.
27Selvaraj, R. J., et al. Microscopic systolic pressure alternans
in human cardiomyopathy: non invasive evaluation of a
novel risk marker and correlation with microvolt T-wave
alternans. Heart Rhythm 8:236–243, 2011.
28Shusterman, V., A. Goldberg, and B. London. Upsurge in
T-wave alternans and nonalternating repolarization insta-
bility precedes spontaneous initiation of ventricular tach-
yarrhythmias in humans. Circulation 113:2880–2887, 2006.
29Surawicz, B., and C. Fisch. Cardiac alternans: diverse
mechanisms and clinical manifestations. J. Am. Coll. Car-
diol. 20:483–499, 1992.
30van Duijvenboden, S., et al. Effect of autonomic blocking
agents on the respiratory-related oscillations of ventricular
action potential duration in humans. Am. J. Physiol. Heart
Circ. Physiol. 309:H2108-17, 2015.
31Verrier, R. L., et al. Microvolt T-wave alternans: Physio-
logical basis, methods of measurement, and clinical utility
consensus guideline by international society for Holter and
non invasive electrocardiology. J. Am. Coll. Cardiol.
58:1309–1324, 2011.
32Zhang, G., M. Gao, D. Xu, N. B. Olivier, and R.
Mukkamala. Pulse arrival time is not an adequate surro-
gate for pulse transit time as a marker of blood pressure. J.
Appl. Physiol. 111:1681–1686, 2011.
33Zhou, X., et al. In vivo and in silico investigation into
mechanisms of frequency dependence of repolarization
alternans in human ventricular cardiomyocytes. Circ. Res.
118:266–278, 2016.
Publisher’s Note Springer Nature remains neutral with re-





Cardiovascular Correlates of Mechanical Alternans
